SE0402433D0 - New composition and method - Google Patents

New composition and method

Info

Publication number
SE0402433D0
SE0402433D0 SE0402433A SE0402433A SE0402433D0 SE 0402433 D0 SE0402433 D0 SE 0402433D0 SE 0402433 A SE0402433 A SE 0402433A SE 0402433 A SE0402433 A SE 0402433A SE 0402433 D0 SE0402433 D0 SE 0402433D0
Authority
SE
Sweden
Prior art keywords
hgf
pharmaceutical composition
new composition
dose sufficient
immunisation
Prior art date
Application number
SE0402433A
Other languages
Swedish (sv)
Inventor
Farba Nayeri
Original Assignee
Damavand Wound Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Damavand Wound Ab filed Critical Damavand Wound Ab
Priority to SE0402433A priority Critical patent/SE0402433D0/en
Publication of SE0402433D0 publication Critical patent/SE0402433D0/en
Priority to PCT/SE2005/001493 priority patent/WO2006038880A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a pharmaceutical composition comprising HGF (Hepatocyte growth factor) and to the use of HGF for the manufacture of such pharmaceutical composition comprising HGF in a dose sufficient for the immunisation in a mammal suffering from cancer. The invention further relates to a method for the treatment cancer using the 5 pharmaceutical composition comprising HGF in a dose sufficient to cause an active immunisation in a mammal.
SE0402433A 2004-10-08 2004-10-08 New composition and method SE0402433D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0402433A SE0402433D0 (en) 2004-10-08 2004-10-08 New composition and method
PCT/SE2005/001493 WO2006038880A1 (en) 2004-10-08 2005-10-07 New composition and method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0402433A SE0402433D0 (en) 2004-10-08 2004-10-08 New composition and method

Publications (1)

Publication Number Publication Date
SE0402433D0 true SE0402433D0 (en) 2004-10-08

Family

ID=33434208

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0402433A SE0402433D0 (en) 2004-10-08 2004-10-08 New composition and method

Country Status (2)

Country Link
SE (1) SE0402433D0 (en)
WO (1) WO2006038880A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL405768A1 (en) * 2013-10-24 2015-04-27 Celther Polska Spółka Z Ograniczoną Odpowiedzialnością Application of EGFR and HGFR agonists as anticancer drugs, acting on cancer cells with specified phenotype

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
JP3927248B2 (en) * 1995-07-11 2007-06-06 第一製薬株式会社 HGF lyophilized formulation

Also Published As

Publication number Publication date
WO2006038880A1 (en) 2006-04-13

Similar Documents

Publication Publication Date Title
NO20062504L (en) Compositions and dosage forms for improved absorption
NO20065726L (en) Compounds and compositions for delivery of active compounds.
DK1933833T3 (en) Therapy for the treatment of overactive bladder
BRPI0618488A2 (en) Hepatocyte Growth Factor Intron Fusion Proteins
DE60133555D1 (en) COMPOUNDS AND MIXTURES FOR THE ADMINISTRATION OF AN ACTIVE AGENCY
HK1156515A1 (en) Pharmaceutical compositions and methods for accelerating wound healing
DE602004027936D1 (en) TOCOPHEROL-MODIFIED THERAPEUTIC DRUG COMPOUND
BRPI0418745A (en) cell line antibody, pharmaceutical composition, and method of treating cancer in a patient
DK1539166T3 (en) Pharmaceutical compositions containing dextromethorphan and quinidine for the treatment of neurological disorders
MX2007008379A (en) Methods and compositions for minimizing accrual of inhalable insulin in the lungs.
DK1346041T3 (en) Therapeutic agents and methods for their use in the treatment of an amyloidogenic disease
CY1118179T1 (en) PHARMACEUTICAL COMPOSITION
ATE499098T1 (en) USE OF PARP-1 INHIBITORS
MX349188B (en) Sns-595 and methods of using the same.
IS6558A (en) Mixed disease treatment with vasoconstrictor
ATE452884T1 (en) ARYLMETHYLAMINE DERIVATIVES FOR USE AS INHIBITORS OF TRYPTASE
CY1110369T1 (en) NEW COOPERATIVE COMBINATION THAT INCLUDES Roflumilast And Formoterol
EA200501821A1 (en) PHARMACEUTICAL COMBINATION, CONTAINING MODAFINIL AND OTHER DRUG PREPARATION
EA200501166A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF THROMBOCYTHEMIA
SE0402433D0 (en) New composition and method
DK1596879T3 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
SE0004827D0 (en) Therapeutic compounds
SE0301884D0 (en) New use III
ATE540920T1 (en) AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN THERAPY
SE0103210D0 (en) New formulations and use thereof